Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $64768.0.

  • Ensysce Biosciences' Non-cash Items fell 8884.11% to $64768.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $64768.0, marking a year-over-year decrease of 8884.11%. This contributed to the annual value of $38734.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Ensysce Biosciences' Non-cash Items is $64768.0, which was down 8884.11% from $51758.0 recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Non-cash Items registered a high of $53.7 million during Q2 2021, and its lowest value of $23922.0 during Q1 2023.
  • Its 5-year average for Non-cash Items is $5.0 million, with a median of $279306.0 in 2022.
  • Its Non-cash Items has fluctuated over the past 5 years, first crashed by 9991.34% in 2022, then surged by 226855.34% in 2024.
  • Quarter analysis of 5 years shows Ensysce Biosciences' Non-cash Items stood at $10.2 million in 2021, then tumbled by 97.26% to $279306.0 in 2022, then crashed by 91.23% to $24505.0 in 2023, then soared by 58.07% to $38734.0 in 2024, then skyrocketed by 67.21% to $64768.0 in 2025.
  • Its last three reported values are $64768.0 in Q3 2025, $51758.0 for Q2 2025, and $38749.0 during Q1 2025.